Plasbumin is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Albumin Human.
| Product ID | 13533-690_21a20866-f2c2-4b6d-9a3f-acd2cc1b9f4a | 
| NDC | 13533-690 | 
| Product Type | Plasma Derivative | 
| Proprietary Name | Plasbumin | 
| Generic Name | Albumin (human) | 
| Dosage Form | Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 1994-09-26 | 
| Marketing Category | BLA / BLA | 
| Application Number | BLA101138 | 
| Labeler Name | GRIFOLS USA, LLC | 
| Substance Name | ALBUMIN HUMAN | 
| Active Ingredient Strength | 3 g/50mL | 
| Pharm Classes | Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 1994-09-26 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | BLA | 
| Application Number | BLA101138 | 
| Product Type | PLASMA DERIVATIVE | 
| Marketing Start Date | 2012-12-05 | 
| Marketing Category | BLA | 
| Application Number | BLA101138 | 
| Product Type | PLASMA DERIVATIVE | 
| Billing Unit | ML | 
| Marketing Start Date | 1994-09-26 | 
| Marketing Category | BLA | 
| Application Number | BLA101138 | 
| Product Type | PLASMA DERIVATIVE | 
| Marketing Start Date | 1994-09-26 | 
| Marketing Category | BLA | 
| Application Number | BLA101138 | 
| Product Type | PLASMA DERIVATIVE | 
| Billing Unit | ML | 
| Marketing Start Date | 1994-09-26 | 
| Marketing Category | BLA | 
| Application Number | BLA101138 | 
| Product Type | PLASMA DERIVATIVE | 
| Billing Unit | ML | 
| Marketing Start Date | 2012-12-05 | 
| Marketing Category | BLA | 
| Application Number | BLA101138 | 
| Product Type | PLASMA DERIVATIVE | 
| Billing Unit | ML | 
| Marketing Start Date | 2012-12-05 | 
| Ingredient | Strength | 
|---|---|
| ALBUMIN HUMAN | 2.5 g/50mL | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 13533-683 | Plasbumin | Albumin (Human) | 
| 13533-684 | Plasbumin | Albumin (Human) | 
| 13533-690 | Plasbumin | Albumin (Human) | 
| 13533-691 | Plasbumin | Albumin (Human) | 
| 13533-692 | Plasbumin | Albumin (Human) | 
| 0053-7680 | Albuminar-25 | Albumin (Human) | 
| 0053-7670 | Albuminar-5 | Albumin (Human) | 
| 44206-251 | AlbuRx | ALBUMIN (HUMAN) | 
| 44206-310 | ALBURX | ALBUMIN (HUMAN) | 
| 68516-5214 | ALBUTEIN | ALBUMIN (HUMAN) | 
| 68516-5215 | ALBUTEIN | ALBUMIN (HUMAN) | 
| 68516-5216 | ALBUTEIN | ALBUMIN (HUMAN) | 
| 61953-0001 | HUMAN ALBUMIN GRIFOLS | ALBUMIN (HUMAN) | 
| 61953-0002 | HUMAN ALBUMIN GRIFOLS | ALBUMIN (HUMAN) | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() PLASBUMIN  73197739  1136564 Live/Registered  | 
        CUTTER LABORATORIES, INC.  1978-12-21  |